FIELD: medicine, hematology.
SUBSTANCE: method consists in long-term complex administration of low-calorie diet, 200 mg of labetalole twice a day, and 2 mg of lacidipine every morning, to correct platelet hemostasis in metabolic syndrome patients. The method allows primary hemostasis normalisation in metabolic syndrome patients during 2 months, due to ADP and ATP levels normalisation, as well as actin and myosin level and assemblage normalisation in platelets.
EFFECT: primary hemostasis normalisation in metabolic syndrome patients.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF LEVELLING OF DYSFUNCTIONS OF THROMBOCYTES AT PERSONS WITH METABOLIC SYNDROME | 2007 |
|
RU2338529C1 |
| METHOD FOR NORMALIZING THROMBOCYTIC DISORDERS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268046C1 |
| METHOD OF DECREASED THROMBOCYTE ACTIVITY IN PATIENTS SUFFERING FROM METABOLIC SYNDROME | 2007 |
|
RU2345764C2 |
| METHOD FOR CORRECTING THROMBOCYTIC DYSFUNCTIONS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268041C1 |
| METHOD FOR THROMBOCYTE DISORDERS CORRECTION IN METABOLIC SYNDROME | 2007 |
|
RU2342136C2 |
| METHOD FOR OPTIMISATION OF THROMBOCYTE FUNCTIONS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2339380C1 |
| TREATMENT METHOD FOR PLATELET DYSFUNCTION IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342134C1 |
| METHOD OF FUNCTIONAL ABILITY NORMALISATION | 2007 |
|
RU2342128C1 |
| METHOD OF LEVELLING OF DYSFUNCTIONS OF THROMBOCYTES IN CONDITIONS OF METABOLIC SYNDROME | 2007 |
|
RU2343916C1 |
| TREATMENT METHOD FOR PRIMARY HEMOSTASIA DISORDERS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342137C2 |
